Interleukin-4 transgenic mice develop glomerulosclerosis independent of immunoglobulin deposition.
Mice with constitutive transgenic (tg) expression of IL-4 develop autoimmune-type disorders resembling human lupus nephritis. The kidneys show progressive glomerulosclerosis with immunoglobulin (Ig) and complement deposition. This study investigated the roles of renal IL-4 expression and glomerular Ig deposition in the pathogenesis of glomerulosclerosis in IL-4 tg mice. Treatment of these mice with IL-4 neutralizing antibody prevented renal disease. IL-4 tg mice treated with methylprednisolone (MP) showed increased mesangial collagen deposition with only trace amounts of glomerular Ig. To analyze the relevance of Ig deposition in the development of the renal lesions, IL-4 tg mice were cross-bred with mu chain-deficient mice (muMT-/-), which are unable to produce Ig. IL-4 tg/muMT-/- mice developed progressive glomerulosclerosis with mesangial accumulation of collagen types I, IV and V despite complete absence of glomerular Ig deposits. Renal IL-4 expression was observed in both anti-IL-4- and MP-treated IL-4 tg mice as well as in IL-4 tg/muMT-/- mice. No statistical difference in the number of glomerular T cells and macrophages between any of the groups was evident. Our data demonstrate that in this model glomerulosclerosis can develop independently of and prior to Ig deposition, and suggest that the initial accumulation of glomerular extracellular matrix is due to renal IL-4 expression. Our results point to a novel mechanism for the development of glomerulosclerosis which may have implications for human disease.
Rüger
B M
BM
Department of Medicine, Wellington School of Medicine, New Zealand.
Erb
K J
KJ
He
Y
Y
Lane
J M
JM
Davis
P F
PF
Hasan
Q
Q
D000818:Animals; D003094:Collagen / Q000378:metabolism; D005260:Female; D007148:Immunoglobulin mu-Chains / Q000502:physiology; D007136:Immunoglobulins / Q000378:metabolism*; D015847:Interleukin-4 / Q000502:physiology*; D007678:Kidney Glomerulus / Q000473:pathology*; D008775:Methylprednisolone / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D012598:Sclerosis
D007148:Immunoglobulin mu-Chains; D007136:Immunoglobulins; D015847:Interleukin-4; D003094:Collagen; D008775:Methylprednisolone